Josh Hall

Bachelor of Medicine and Bachelor of Science,  Cleveland Clinic 

Location: Germany

Consulting Services

Research Consulting Data Science-Bioinformatics

Areas Of Interest

Aluminum rab4 GTP-Binding Proteins Area Health Education Centers Ligaments, Flaval Glycoprotein, NILE Retropubic Prostatectomy Agents, Major Tranquilizing Ears, Inner Cytoplasmic Exosome Complex Hemorrhages, Spinal Epidural Stimulation, Acoustic ailanthoide, Fagara Type I Protein Arginine N-Methyltransferase Reichels Syndrome Mother, Host Viruses, Tobacco Mosaic Transplants, Tissue Tc-PYP Suicides, Physician-Assisted Medicines, Mongolian Traditional Kinase, Opsin E47 Helix-Loop-Helix Protein Cross Eye D-Amino Acid Dehydrogenase Adaptive Clinical Trial as Topic Galactose, Uridine Diphosphate Repetitive Sequence, Simple Hydrochloride, Aminolevulinic Acid Torsion, Mechanical Cystine Knot Motifs D D Carboxypeptidase Cystatin 4

Professional Narrative

Dr. Josh Hall was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Hall has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Amgen 1989
Assistant Professor, Mayo Clinic 2007

Education

Doctor of osteopathic medicine, Yale School of Medicine 1996
Director Medicine, Baylor College 1994

Referees


Publications

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :